International Flavors & Fragrances (IFF) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
15 Oct, 2026Executive summary
Q4 sales were $2.703B, down 5% reported but up 1% on a comparable currency-neutral basis; adjusted operating EBITDA rose 17% on that basis.
FY 2023 sales were $11.479B, down 8% reported and 1% comparable currency-neutral; adjusted operating EBITDA was $1.98B, down 10% comparable currency-neutral.
A $2.623B non-cash goodwill impairment drove reported losses; management cited sequential volume improvement and cautious optimism for 2024.
FY sales and adjusted operating EBITDA were within guidance; 2024 targets call for improved volumes and EBITDA growth amid macroeconomic uncertainty.
Financial highlights
Q4 revenue was $2.703B versus $2.844B a year earlier; adjusted operating EBITDA was $461M versus $441M, and margin rose to 17.1% from 15.5%.
Q4 reported EPS was $(10.21); adjusted EPS excluding amortization was $0.72 per diluted share.
FY reported EPS was $(10.05); adjusted EPS excluding amortization was $3.34 per diluted share.
FY reported net loss attributable to shareholders was $2.567B, versus $1.871B in 2022.
FY operating cash flow was $1.44B and free cash flow was $936M.
Outlook and guidance
FY 2024 revenue guidance is $10.8B–$11.1B; volume outlook is 0%–3%, with pricing expected to decline ~2.5%.
FY 2024 adjusted operating EBITDA guidance is $1.9B–$2.1B; comparable currency-neutral adjusted EBITDA growth is projected at 3%–11%.
FX is expected to reduce 2024 sales growth by 0%–1% and adjusted EBITDA growth by ~2%–3%, based on current market rates.
Sequential volume improvement is expected to continue, though recovery pace and scale remain unclear; all divisions target volume improvement and margin expansion.
Productivity initiatives are intended to offset cost inflation, incentive-compensation reset and reinvestment; cash generation and working-capital improvement remain priorities.
Latest events from International Flavors & Fragrances
- Volume-led Q3 growth lifted FY26 guidance, despite cost pressure and a held-for-sale impairment.IFF
Q3 2026 - Transformation to three innovation-led units and operational focus drive sustainable growth.IFF
Barclays 19th Annual Global Consumer Conference - Q2 2026 saw robust growth, portfolio transformation, and a $2.5B buyback amid legal risks.IFF
Q2 2026 - Q1 2026 delivered 3% sales and 8% EBITDA growth, with all segments expanding and guidance reaffirmed.IFF
Q1 2026 - All proposals passed, directors elected, and no shareholder questions were raised.IFF
AGM 2026 - 2025 delivered 2% currency-neutral sales and 7% EBITDA growth, with major portfolio shifts and margin gains.IFF
Q4 2025 - Strong Q3 growth and raised 2024 outlook driven by volume recovery and margin gains.IFF
Q3 2024 - Strong 2024 results and bioscience innovation drive growth and transformation in 2025.IFF
Consumer Analyst Group of New York Conference 2025 - Strong 2024 results with margin gains; 2025 outlook faces FX and divestiture headwinds.IFF
Q4 2024